Plasma levels of pro-inflammatory markers, such as C-reactive protein and IL-18, have been reported to be associated with increased risk of T2D (Freeman et al. 2002; Thorand et al. 2005). The gene discussed is CRP; the disease is type 2 diabetes mellitus.